What a Cardiopulmonary Resuscitation Device Business Actually Is

Search "cardiopulmonary resuscitation device" and you land on two very different businesses wearing the same words. One is a device venture: a company that sells, rents and services automated CPR machines and the closely related automated external defibrillator (AED) category, plus the consumables those machines burn through. The other is a CPR training school that earns class fees teaching people to do compressions by hand. They share a phrase and almost nothing else. This template is built for the first one, because that is what a "device" plan has to fund: capital equipment, regulated supply, and a service book.

The distinction matters the moment you open a spreadsheet. A training school can start on $3,200–$8,000 and bill per seat. A device distributor has to stock units that cost as much as a used car each, register with a regulator before importing a single box, and earn most of its profit from the unglamorous stream of replacement pads, batteries and service visits that follow the sale. If your plan reads like a clinic or a class schedule, a lender who knows the category will spot it in thirty seconds.

The good news is that the device side is genuinely investable. Demand is structural rather than fashionable: cardiac arrest does not go out of style, public-access defibrillation keeps expanding, and every device placed creates a multi-year consumable and compliance relationship. The rest of this guide builds the plan around those facts, costs first, then the entry models, supply, regulation, and the economics that make the numbers hold together.

Who buys from you

• EMS and ambulance services buying mechanical CPR units to free a crew member during transport, high-value, tender-driven, relationship-led.
• Hospitals and clinics standardising resuscitation kit across departments, where hospitals make up roughly 56% of resuscitation-device end users.
• Schools, gyms, workplaces and public venues buying AEDs, often as a managed package with training and compliance built in.
• Film, event and remote-medical operators renting compression units for standby cover rather than owning them.

Each of these buyers values something different, and the plan should say so rather than describing a single generic "customer". An EMS director buys clinical evidence, durability and serviceability; a school or gym buys reassurance and a hands-off compliance arrangement; an event medical provider buys availability on a date. That divergence shapes both pricing and the go-to-market motion, because the channels that reach a hospital procurement committee are not the channels that reach a chain of fitness studios.

How the plan should position the venture

Positioning in this category is rarely about being the cheapest box. The distributors that defend margin compete on total cost of ownership: uptime, consumable supply, training and service rolled into one relationship, rather than on the sticker price of the device. A strong plan therefore frames the company as a long-term resuscitation-readiness partner for its customers, with the hardware sale as the entry point to a multi-year relationship. That framing also explains the marketing motion: qualified inbound from search and referral for AED buyers, direct and tender-led selling for EMS and hospitals, and partnership channels (first-aid trainers, facilities managers, occupational-health providers) that put devices in front of the right decision-makers. Tie each channel to a cost of acquisition and an expected attach rate for service contracts, and the sales forecast stops being a guess.

What It Costs To Launch

Starting a cardiopulmonary resuscitation device business typically takes $92K to $555K (£72K to £438K) depending on whether you launch as a lean single-territory reseller or a stocked regional distributor with its own service capability. The single biggest swing factor is inventory: the demo and loan-pool units you must put in front of buyers before they commit to a $15,000 purchase.

Line-by-line build-up

• Demo / loan-pool device inventory: $30K–$140K (£24K–£110K), two to four mechanical CPR units plus AED demo stock
• Opening consumables stock: $12K–$70K (£9K–£55K), electrode pads, batteries, suction cups, LifeBands
• Regulatory & quality: $10K–$55K (£8K–£43K), FDA establishment registration, ISO 13485 groundwork, UKCA/CE conformity, distributor agreements
• Sales team, clinical educators & field service training: $15K–$95K (£12K–£75K)
• Compliance / asset-tracking software, e-commerce and CRM: $8K–$45K (£6K–£35K)
• Marketing, tenders & trade-show presence: $10K–$80K (£8K–£63K)
• Product liability & professional indemnity insurance: $4K–$30K (£3K–£24K)

How founders fund it

In the US, the SBA 7(a) loan is the workhorse. The average 7(a) loan in fiscal year 2024 was $443,097, down from $479,685 in 2023 (Crestmont Capital, 2025), comfortably inside the range a device distributor needs, and in May 2026 the SBA doubled the cumulative 7(a)/504 borrower limit to $10 million (U.S. Small Business Administration, 2026). Equipment lines are well-suited to financing demo fleets because the device itself is collateral. A medical-equipment wholesaler files under NAICS 423450, which carries an SBA size standard of 200 employees, so a startup is firmly within scope. In the UK, a Start Up Loan of up to £25,000 at 6% fixed seeds the early stock, usually alongside asset finance against the device inventory and a working-capital facility for consumables.

What a lender actually checks

A device distributorship is read differently from a service business because so much of the capital is locked in stock. Underwriters tend to focus on four things. The first is inventory turn: how quickly demo and saleable stock converts to revenue, because slow-moving $15,000 units sitting in a warehouse are dead collateral. The second is the recurring-revenue ratio: the share of forecast revenue that comes from consumables and service rather than one-off hardware, since that is what makes repayments predictable. The third is supplier security: a signed or letter-of-intent distributor agreement with a recognised platform de-risks the whole plan, while "we will source devices" reads as a red flag. The fourth is the personal and clinical credibility of the founder, because relationships with EMS and hospital buyers are the real moat in this category.

Build the plan so each of those four questions is answered before it is asked. A monthly cash-flow statement for Year 1 should show the inventory drawdown and the lag between buying stock and collecting payment, especially where public-sector buyers pay on 30-to-60-day terms. The financing mix should pair a term loan for fixed setup with an asset-backed line that flexes with inventory, so you are not funding slow-turning hardware with expensive short-term money.

Three Ways To Enter The Market

Most operators do not start by stocking $20,000 piston devices. They pick an entry model that matches their capital and their network, then layer the others on. Map yours honestly in the plan, because the three differ sharply on capital, margin shape and how fast cash comes back.

The pattern that wins is rarely a single lane. A distributor that starts AED-led to generate cash, then adds mechanical-CPR demos once it has EMS relationships, and finally a rental fleet for event work, ends up with three revenue clocks ticking at different speeds. The recurring layers are what convert a hardware reseller into something a lender will underwrite, because they smooth the lumpy capital-sale cycle that makes pure resale look risky on paper.

Each model also has a different sales cadence, and your operating plan should reflect it. AED-led distribution is closest to volume B2B selling: shorter cycles, smaller tickets, and a managed-service upsell that you pitch on the same call. Mechanical-CPR distribution behaves like enterprise capital sales, with evaluation periods, clinical sign-off, and procurement or tender processes that can run several months from first demo to purchase order. Rental is closer to an asset-utilisation business, where the metric that matters is days hired per unit per month rather than units sold. Founders who try to run all three on one playbook usually underprice the long mechanical-CPR cycle and overcommit demo stock; treating them as separate motions, with separate targets, is what keeps cash discipline intact.

Operations: where margin is actually protected

Because the product is regulated and the cash is tied up in stock, operations are not a footnote in this plan, they are where the forecast is defended. Four disciplines deserve explicit treatment. Inventory and demo-pool management determines how much capital is idle at any moment; a tracked loan pool with clear evaluation deadlines stops $15,000 units from disappearing into a prospect's storeroom for six months. Consumable fulfilment is the engine of the recurring book, so reorder reminders, subscription billing for pads and batteries, and expiry tracking are operational must-haves, not nice-to-haves. Field service: preventive maintenance, firmware updates, and rapid swap-outs, is what justifies a service contract and keeps a fleet "rescue-ready". And compliance and vigilance, including handling field-safety notices and logging adverse events, is both a legal duty and a trust signal to clinical buyers.

• Asset tracking: every demo, rental and contracted unit logged by serial number, location and service-due date
• Consumable cadence: automated reorder and expiry alerts so pads and batteries are replaced before they lapse
• Service SLAs: defined response and swap-out times that make the contract worth its annual fee
• Documented quality system: traceability and complaint handling aligned to ISO 13485 expectations

For a first-year operator, three milestones are worth committing to in the plan because they prove the model rather than just describing it. The first is the first signed service contract, because it converts a one-off sale into recurring revenue and validates the attach-rate assumption. The second is demo-pool payback: the point at which the units you bought to win evaluations have generated enough sales to cover their own cost, which tells you the inventory is working capital, not a sunk cost. The third is the first tender win with an EMS service or hospital, which both opens up volume and gives every subsequent buyer a reference. Mapping the year to those three proof points keeps the focus on the metrics a lender or investor will actually grade you on.

Licensing & Regulatory Path

Resuscitation devices are regulated medical devices, and the rules differ by where the device is sold rather than where you are based. You are usually the distributor, not the manufacturer, so you do not file the clearance, but you carry real registration, vigilance and quality obligations that belong in the plan and on the cost line.

United States

• Mechanical chest compressors are Class II devices, product code DRM, classification regulation 21 CFR 870.5200 (External Cardiac Compressor)
• The manufacturer holds the 510(k) clearance: for example the ZOLL AutoPulse Model 100 was cleared under 510(k) K112998 (FDA, 2012)
• As a distributor you complete FDA establishment registration and device listing and operate under the Quality System Regulation (21 CFR 820)
• Add any state medical-device wholesaler licence; no DEA registration is needed (no controlled substances)

United Kingdom

• Devices carry UKCA or CE marking under the UK Medical Devices Regulations 2002 (as amended), overseen by the MHRA
• UK importers and distributors must register with the MHRA and meet UK Responsible Person obligations
• Authorised-distributor status matters: Defib Store and defibshop are examples of authorised UK Stryker LUCAS distributors with training and servicing tied in
• Ongoing post-market surveillance and field-safety-notice handling are required

European Union & Canada

• EU: mechanical chest-compression devices are Class IIb under EU MDR 2017/745, needing a Technical File, an EU Authorised Representative, a Notified Body audit, and CE mark plus UDI
• Canada: active resuscitation devices are generally Class III under the Canadian Medical Devices Regulations, requiring a product-specific Medical Device Licence (MDL) from Health Canada, with importers also holding a Medical Device Establishment Licence (MDEL)

Two wording traps cost founders credibility. First, never write that a mechanical CPR device is "FDA approved", it is 510(k) cleared, and the difference is the first thing a clinical buyer checks. Second, do not assume a CE classification carries to Canada; the class numbering is different and the licence is separate.

Revenue, Margins & A Worked Example

The mistake that sinks most cardiopulmonary resuscitation device plans is treating the business as a hardware shop. Hardware is the hook; the annuity is the business. Spell out both layers so the forecast survives a lender's read.

Revenue streams

• Capital device sales: LUCAS 3.1 around $15,000–$20,000 (UK ~£10,400 ex VAT); AutoPulse comparable; AEDs $1,200–$2,500
• Consumables: pad sets, batteries and LifeBands at $80–$400 per device per year, high frequency, high margin
• Managed-AED & service contracts: $150–$500 per device per year for compliance checks, readiness monitoring and servicing
• Rental: mechanical CPR units to events, film and standby medical at $250–$600 per day

Gross margin runs 22–40% on hardware: tender pricing keeps it honest, but 55–70% on consumables and service. Blended net margin lands at 9–22% once the recurring book is large enough to carry fixed cost. This is the same lesson the wider channel has learned: distributors such as Safe Life, valued at about EUR 500 million by Bridgepoint in 2025, capture margin through service and compliance software rather than the box itself.

How to think about pricing

Pricing a regulated capital device is not the same as marking up a catalogue. On hardware you are usually anchored by the manufacturer's pricing and by what competing tenders bid, so the room to differentiate sits in the wrap-around: training, an extended warranty, a guaranteed swap-out, or a consumables subscription that locks in the recurring revenue. On AEDs, the smarter play is often to hold a competitive hardware price and make the economics on a multi-year managed programme rather than the device itself. On rental, price per day has to clear not just the device's depreciation but the cost of keeping a unit serviced, charged and rescue-ready between hires, which is why day rates of $250–$600 are not as generous as they first look once utilisation is honest.

Two numbers belong in the forecast that founders routinely omit. The first is the service-attach rate: the percentage of device sales that convert into an ongoing consumable or service contract, which is the single biggest lever on lifetime value. The second is replacement cadence: AED pads and batteries expire on a known schedule (typically every two to five years), so a fleet of contracted devices produces a forecastable wave of consumable reorders that should appear explicitly in the model rather than being buried in a generic "other revenue" line.

Market Size & Demand Signal

The global resuscitation devices market reached $6.02B in 2025 and is forecast to hit $8.43B by 2031 at a 5.77% CAGR, with North America holding 37.1% of revenue and hospitals making up 56.45% of end users (Mordor Intelligence, 2025). The narrower CPR-devices segment was valued at $132.42M in 2025 and is growing faster, at 10.7% CAGR (Reanin, 2025).

What makes the demand durable is the clinical reality underneath it. The US records more than 357,000 out-of-hospital cardiac arrests a year, and survival to discharge sits at roughly 10.5%, but rises to 13.0% when a bystander performs CPR, versus 7.6% without (AHA / CARES registry, 2024). In the UK there are more than 30,000 such arrests annually, survival is about one in twelve, and a public-access defibrillator is now used in roughly 10% of cases (British Heart Foundation / Resuscitation Council UK, 2024). Every percentage point of improvement is a policy goal, and policy goals translate into device budgets. The home-care channel is the fastest-growing end-user segment at 7.61% CAGR, which is why AED-led distribution into community settings is such a viable on-ramp.

Reading the segmentation

The headline market number hides the part that matters for your plan: which segment is actually growing and where the easy volume sits. Within resuscitation devices, airway-management products hold the largest single slice at around 41% of revenue, with external defibrillators the second-largest segment. Mechanical CPR devices are a small but fast-growing niche, expanding at a double-digit pace as ambulance services and hospitals adopt them for transport and prolonged resuscitation. The practical reading for a distributor is that AEDs and consumables give you reachable volume and a recurring base today, while mechanical CPR is the higher-ticket, faster-growing layer you grow into. A plan that leans entirely on the small mechanical-CPR niche will look thin; one that leans entirely on commodity AED resale will look low-margin. The investable position sits in the blend.

Geography matters too. North America's 37.1% revenue share reflects mature reimbursement and dense EMS infrastructure, which is why the US is the deepest market for high-value mechanical units. Europe grows steadily under tighter procurement, and Asia-Pacific is the fastest-expanding region at roughly 9% CAGR as public-access defibrillation programmes scale. If your plan has any export or multi-market ambition, name the sequence and the regulatory cost of each step rather than implying you can sell everywhere at once.

The structural tailwind worth naming explicitly is the public-access defibrillation movement. Registries that map and maintain community AEDs, in workplaces, transport hubs, schools and sports facilities, generate recurring demand not just for devices but for the pads, batteries and readiness checks that keep them usable. That is precisely the annuity a distributor wants to own, and it is growing because the clinical case for bystander-accessible devices is now settled policy on both sides of the Atlantic.

Devices, Brands & Supply

Your plan needs a named supply chain, not "we will source devices". Buyers and lenders both want to see which platforms you carry and that you have a route to authorised stock. These are the devices and channels that define the category.

• Stryker LUCAS 3.1: the most widely used pneumatic piston compression system; UK list around £10,400 ex VAT, US roughly $15,000–$20,000
• ZOLL AutoPulse Model 100: load-distributing-band compressor (the LifeBand is a recurring single-use consumable); FDA Class II, code DRM
• Defibtech Lifeline ARM / ARM XR: automated chest compression units that broaden the platform mix and price points
• AED brands: ZOLL, Stryker/Physio-Control, Philips and others; the $1,200–$2,500 volume layer that funds the early business
• Authorised UK distributors: Defib Store and defibshop show the authorised-reseller model, bundling device, training and servicing
• Consumables supply: electrode/defib pad sets, lithium batteries, suction cups and LifeBands, the items that drive the recurring book

One structural decision belongs here: do you become an authorised distributor for a single platform, with the training and service backing that brings, or a multibrand reseller that competes on choice and total cost of ownership? Both are valid; investors simply want to see you have chosen and understand the trade-off. Authorised single-platform status usually means better margins, factory training and warranty backing, but it ties your fortunes to one manufacturer's roadmap and pricing. The multibrand route gives you more negotiating room and a broader catalogue, at the cost of thinner per-unit support and the overhead of maintaining competence across several systems.

Key terms buyers will expect you to know

• Mechanical / automated CPR (mCPR): a device that delivers chest compressions automatically, by piston or constricting band, as an adjunct to manual CPR.
• Load-distributing band (LDB): the AutoPulse mechanism that squeezes the whole thorax; the band itself is a single-patient-use consumable.
• AED: automated external defibrillator, analyses heart rhythm and delivers a shock; the high-volume product class and a common entry point for a distributor.
• 510(k) clearance: the US route by which a Class II device is marketed on the basis of substantial equivalence to a legally marketed predicate.
• UDI: unique device identifier, the traceability code required on regulated devices in the US and EU.
• Managed AED programme: a service contract bundling readiness checks, pad/battery replacement and compliance reporting around a customer's device fleet.

Mistakes That Sink The Plan

These are the errors that get cardiopulmonary resuscitation device plans declined or that quietly wreck the unit economics after launch.

• Pricing the business on hardware margin alone. Ignore the consumables and service annuity and your plan looks like a low-margin box-shifter; model the recurring layer and the same business becomes fundable.
• Calling the device "FDA approved". Mechanical CPR compressors are 510(k) cleared Class II (code DRM). Clinical buyers and lenders notice the wrong word immediately.
• Budgeting demo inventory at zero. You cannot sell a $15K capital device without leaving evaluation units on site. Loan-pool stock is a real, large line item, not an afterthought.
• Skipping distributor registration. Importing before MHRA registration (UK), FDA establishment registration (US), or appointing an EU Authorised Representative is a compliance and reputational risk that surfaces in due diligence.
• Confusing this with a CPR training school. A training business starts on ~$3,200–$8,000 and bills class fees. Borrowing that model into a device plan produces a forecast a category lender will not believe.

More Questions Founders Ask

How big is the CPR device market really?

It depends where you draw the line. The narrow "CPR devices" segment is about $132M (2025), the broader resuscitation-devices market is $6.02B, and external defibrillators add another $3.84B (2024) with AEDs making up roughly 40% of that. A realistic plan sizes the slice you actually sell into rather than quoting the largest possible number.

Can I start with AEDs and add mechanical CPR later?

Yes, and most successful operators do. AEDs at $1,200–$2,500 generate cash and build a managed-service book quickly; mechanical CPR demos at $15K–$20K are added once you have EMS and hospital relationships that justify the inventory commitment.

What margin should I model on consumables?

Plan for 55–70% gross on pads, batteries and bands, against 22–40% on hardware. The consumable and service mix is what lifts blended net margin into the 9–22% range and what makes the recurring revenue defensible.

Is rental worth the capital tie-up?

For event, film and remote-medical standby it can be, at $250–$600 per device per day. Rental keeps utilisation on fleet you already own and creates a third revenue clock, but it only works once you have enough units that idle time is the exception rather than the rule.

Sample Business Plan Preview

Preview the structure and financial outputs a buyer receives. These visual mockups are generated from the same assumptions used throughout this page.

What's In The Template

Every Avvale business plan template includes these sections, pre-structured for a cardiopulmonary resuscitation device venture:

• Executive Summary: your device business at a glance, written to hook a lender in 60 seconds
• Company Overview: legal structure, distributor agreements, location, and founding story
• Industry Analysis: resuscitation-device and AED market data, growth, and the cardiac-arrest demand signal
• Customer Analysis: EMS, hospitals, schools, gyms and event operators, with buying triggers
• Competitor Analysis: platform mapping (LUCAS, AutoPulse, AED brands) and your differentiation
• Marketing Plan: tender response, channel partners, managed-service packaging, and acquisition
• Operations Plan: inventory and demo-pool management, field service, consumable fulfilment, milestones
• Management Team: clinical and sales bios, advisory board, and key hires planned

The optional Financial Forecast add-on (included in our $300/£250 and $1,000/£800 packages) provides a 5-year Excel model with income statement, cash flow, balance sheet, break-even analysis, an inventory-turn schedule, and the hardware-versus-recurring revenue split this business lives or dies on. For adjacent ventures, see our medical device development business plan template, our first aid training business plan template, and our ambulance services business plan template.

Frequently Asked Questions

Useful Links & Resources

Helpful starting points as you build your cardiopulmonary resuscitation device plan and funding case.

• Free business plan templates library
• Market research & content service
• Facebook
• LinkedIn